![(2E)-3-[2,6-Dichloro-4-[[[4-[3-[(1S)-1-(hexyloxy)ethyl]-2-methoxyphenyl]-2-thiazolyl]amino]carbony…](https://static.cymitquimica.com/cas-image/thumb-webp/350315-lusutrombopag.webp)
CAS 1110766-97-6
:(2E)-3-[2,6-Dichloro-4-[[[4-[3-[(1S)-1-(hexyloxy)ethyl]-2-methoxyphenyl]-2-thiazolyl]amino]carbonyl]phenyl]-2-methyl-2-propenoic acid
Description:
The chemical substance known as (2E)-3-[2,6-Dichloro-4-[[[4-[3-[(1S)-1-(hexyloxy)ethyl]-2-methoxyphenyl]-2-thiazolyl]amino]carbonyl]phenyl]-2-methyl-2-propenoic acid, with the CAS number 1110766-97-6, is a complex organic compound characterized by its multi-functional structure. It features a propenoic acid backbone, which contributes to its potential reactivity and biological activity. The presence of dichloro and methoxy groups indicates that it may exhibit unique electronic properties and solubility characteristics. Additionally, the thiazole and phenyl moieties suggest potential interactions with biological targets, making it of interest in medicinal chemistry. The hexoxy substituent may enhance lipophilicity, influencing its pharmacokinetic profile. Overall, this compound's intricate structure suggests it could have applications in pharmaceuticals, particularly in the development of targeted therapies or as a lead compound in drug discovery. However, specific biological activities and safety profiles would require further investigation through experimental studies.
Formula:C29H32Cl2N2O5S
InChI:InChI=1S/C29H32Cl2N2O5S/c1-5-6-7-8-12-38-18(3)20-10-9-11-21(26(20)37-4)25-16-39-29(32-25)33-27(34)19-14-23(30)22(24(31)15-19)13-17(2)28(35)36/h9-11,13-16,18H,5-8,12H2,1-4H3,(H,35,36)(H,32,33,34)/b17-13+/t18-/m0/s1
InChI key:InChIKey=NOZIJMHMKORZBA-KJCUYJGMSA-N
SMILES:O(C)C1=C(C=CC=C1[C@@H](OCCCCCC)C)C=2N=C(NC(=O)C3=CC(Cl)=C(/C=C(/C(O)=O)\C)C(Cl)=C3)SC2
Synonyms:- (2E)-3-[2,6-Dichloro-4-[[[4-[3-[(1S)-1-(hexyloxy)ethyl]-2-methoxyphenyl]-2-thiazolyl]amino]carbonyl]phenyl]-2-methyl-2-propenoic acid
- S 888711
- Lusutrombopag
- 2-Propenoic acid, 3-[2,6-dichloro-4-[[[4-[3-[(1S)-1-(hexyloxy)ethyl]-2-methoxyphenyl]-2-thiazolyl]amino]carbonyl]phenyl]-2-methyl-, (2E)-
- 2-Propenoic acid, 3-[2,6-dichloro-4-[[[4-[3-[(1S)-1-(hexyloxy)ethyl]-2-methoxyphenyl]-2-thiazolyl]amino]carbonyl]phenyl]-2-methyl-, (2E)-
- Mulpleo
- (E)-3-[2,6-dichloro-4-[4-[3-[(S)-1-hexyloxyethyl]-2-methoxyphenyl]thiazol-2-ylcarbamoyl]phenyl]-2-methylacrylic acid
- S888711;S 888711
- S888711
- Lusutrombopag S-888711
Filter by
Purity percentage
0
100
|
0
|
50
|
90
|
95
|
100
Found 10 products.
- Lower prices
- Higher prices
- Lower purities
- Higher purities
- Faster estimated delivery
2-Propenoic acid, 3-[2,6-dichloro-4-[[[4-[3-[(1S)-1-(hexyloxy)ethyl]-2-methoxyphenyl]-2-thiazolyl]amino]carbonyl]phenyl]-2-methyl-, (2E)-
CAS:Formula:C29H32Cl2N2O5SPurity:97%Color and Shape:SolidMolecular weight:591.5458Lusutrombopag
CAS:(S,E)-3-(2,6-Dichloro-4-((4-(3-(1-(hexyloxy)ethyl)-2-methoxyphenyl)thiazol-2-yl)carbamoyl)phenyl)-2-methylacrylic acidFormula:C29H32Cl2N2O5SPurity:97%Molecular weight:591.55Lusutrombopag
CAS:Lusutrombopag (Mulpleta) is an orally bioavailable, small molecule thrombopoietin (TPO) receptor agonist for chronic liver disease (CLD) patients withFormula:C29H32Cl2N2O5SPurity:99.96%Color and Shape:SolidMolecular weight:591.546Lusutrombopag
CAS:Controlled ProductApplications Lusutrombopag is a newly discovered thrombopoietin receptor agonist used in the treatment of patients with chronic ITP.
References Katsube, T. et al.: Clin. Pharmacokinet., 55, 1423 (2016); Siegal, D. et al.: Semin. Hematol., 50, S18 (2013);Formula:C29H32Cl2N2O5SColor and Shape:NeatMolecular weight:591.55Lusutrombopag-d13
CAS:Controlled ProductFormula:C29D13H19Cl2N2O5SColor and Shape:NeatMolecular weight:604.626
![2-Propenoic acid, 3-[2,6-dichloro-4-[[[4-[3-[(1S)-1-(hexyloxy)ethyl]-2-methoxyphenyl]-2-thiazolyl]…](https://static.cymitquimica.com/products/IN/thumb/DA008ZUX.jpg)
